U.S. flag

An official website of the United States government

NM_000256.3(MYBPC3):c.3392T>C (p.Ile1131Thr) AND not specified

Germline classification:
Likely benign (1 submission)
Last evaluated:
Apr 27, 2015
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000035586.3

Allele description

NM_000256.3(MYBPC3):c.3392T>C (p.Ile1131Thr)

Gene:
MYBPC3:myosin binding protein C, cardiac [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p11.2
Genomic location:
Preferred name:
NM_000256.3(MYBPC3):c.3392T>C (p.Ile1131Thr)
HGVS:
  • NC_000011.10:g.47332912A>G
  • NG_007667.1:g.24791T>C
  • NM_000256.3:c.3392T>C
  • NP_000247.2:p.Ile1131Thr
  • LRG_386t1:c.3392T>C
  • LRG_386:g.24791T>C
  • LRG_386p1:p.Ile1131Thr
  • NC_000011.9:g.47354463A>G
  • Q14896:p.Ile1131Thr
  • c.3392T>C
Protein change:
I1131T
Links:
UniProtKB: Q14896#VAR_029428; dbSNP: rs370890951
NCBI 1000 Genomes Browser:
rs370890951
Allele Frequency:
0.0006, GO-ESP
Molecular consequence:
  • NM_000256.3:c.3392T>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
7

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000059236Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Likely benign
(Apr 27, 2015)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided97not providednot providednot providedclinical testing

Citations

PubMed

The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands.

Alders M, Jongbloed R, Deelen W, van den Wijngaard A, Doevendans P, Ten Cate F, Regitz-Zagrosek V, Vosberg HP, van Langen I, Wilde A, Dooijes D, Mannens M.

Eur Heart J. 2003 Oct;24(20):1848-53.

PubMed [citation]
PMID:
14563344

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ.

J Am Coll Cardiol. 2004 Nov 2;44(9):1903-10.

PubMed [citation]
PMID:
15519027
See all PubMed Citations (9)

Details of each submission

From Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine, SCV000059236.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided9not providednot providedclinical testing PubMed (9)

Description

p.Ile1131Thr in exon 31 of MYBPC3: This variant is not expected to have clinical significance because it has been identified in 0.3% (14/4490) of Finnish chromosomes and 0.15% (72/48504) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs370890951). Additionally, isoleucine (Ile) at position 1131 is not conserved in mammals or evolutionarily distant species and 1 mammal (prairie vole) carries a threonine (Thr) at this position, supporting that this change may be tolerated.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided9not provided7not provided

Last Updated: Jun 20, 2017